A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines
- PMID: 2904510
A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines
Abstract
P-glycoprotein, a molecular weight 170 kilodalton membrane component can be accurately detected in a series of human ovarian carcinoma cells with increasing degrees of multidrug resistance by using a modified immunoperoxidase "sandwich" method. Drug-resistant derivatives were selected from a drug-sensitive parent ovarian carcinoma cell line, SKOV3, by continuous exposure to increasing concentrations of the cytotoxic drug vincristine. These cells had corresponding overexpression of P-glycoprotein demonstrable at both protein and mRNA levels. Monoclonal antibodies against P-glycoprotein localized staining for P-glycoprotein to the plasma membrane and the Golgi region in individual drug-resistant cells, in proportion to their P-glycoprotein expression. P-glycoprotein was not demonstrable in drug-sensitive SKOV3 cells by either immunoblotting or immunocytochemical staining methods. The immunocytochemical staining method allowed detection of P-glycoprotein in the least drug-resistant cell line with as low as 8-fold relative resistance to vincristine. This method is as sensitive as Northern blot, and more sensitive than standard Western blot in detection of P-glycoprotein. We conclude that this highly sensitive immunocytochemical staining method for P-glycoprotein can be suitable for determination of P-glycoprotein expression in biopsy samples of tumors, and it can be a powerful diagnostic and prognostic tool in the study of the natural history of drug resistance. This may have important applications in the clinical management of cancer chemotherapy.
Similar articles
-
P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines.Cancer Res. 1989 May 15;49(10):2790-6. Cancer Res. 1989. PMID: 2565764
-
Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies.Lab Invest. 1990 Dec;63(6):815-24. Lab Invest. 1990. PMID: 1979362
-
Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma.Mod Pathol. 1990 May;3(3):298-301. Mod Pathol. 1990. PMID: 1972985
-
A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.Lab Invest. 1994 Oct;71(4):595-603. Lab Invest. 1994. PMID: 7967514
-
[P glycoprotein as a resistance marker in tumors].Dtsch Med Wochenschr. 1989 Dec 1;114(50):1979-81. Dtsch Med Wochenschr. 1989. PMID: 2574661 Review. German. No abstract available.
Cited by
-
Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.World J Surg Oncol. 2005 Sep 14;3:61. doi: 10.1186/1477-7819-3-61. World J Surg Oncol. 2005. PMID: 16164742 Free PMC article.
-
Causes and problems of nonresponse or poor response to drugs.Drugs. 1996 Apr;51(4):552-70. doi: 10.2165/00003495-199651040-00004. Drugs. 1996. PMID: 8706594 Review.
-
Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomas.Am J Pathol. 1992 May;140(5):1009-16. Am J Pathol. 1992. PMID: 1374585 Free PMC article.
-
Overcoming drug resistance in ovarian carcinoma.Curr Oncol Rep. 2001 Jan;3(1):19-26. doi: 10.1007/s11912-001-0038-z. Curr Oncol Rep. 2001. PMID: 11123865 Review.
-
Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones.Br J Cancer. 1996 Feb;73(3):307-15. doi: 10.1038/bjc.1996.54. Br J Cancer. 1996. PMID: 8562335 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical